258 related articles for article (PubMed ID: 16141417)
1. Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window.
Yu YM; Kim JB; Lee KW; Kim SY; Han PL; Lee JK
Stroke; 2005 Oct; 36(10):2238-43. PubMed ID: 16141417
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain.
Kim JB; Yu YM; Kim SW; Lee JK
Brain Res; 2005 Oct; 1060(1-2):188-92. PubMed ID: 16226231
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment with ethyl pyruvate and aspirin enhances neuroprotection in the postischemic brain.
Kim SW; Jeong JY; Kim HJ; Seo JS; Han PL; Yoon SH; Lee JK
Neurotox Res; 2010 Jan; 17(1):39-49. PubMed ID: 19636661
[TBL] [Abstract][Full Text] [Related]
4. Anti-Inflammatory and Neuroprotective Effects of DIPOPA (N,N-Diisopropyl-2-Oxopropanamide), an Ethyl Pyruvate Bioisoster, in the Postischemic Brain.
Lee HK; Park JY; Lee H; Kim ID; Kim SW; Yoon SH; Lee JK
Neurotherapeutics; 2019 Apr; 16(2):523-537. PubMed ID: 30680637
[TBL] [Abstract][Full Text] [Related]
5. Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain.
Shin JH; Lee HK; Lee HB; Jin Y; Lee JK
Neurosci Lett; 2014 Jan; 558():159-63. PubMed ID: 24246904
[TBL] [Abstract][Full Text] [Related]
6. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.
Khan M; Sekhon B; Jatana M; Giri S; Gilg AG; Sekhon C; Singh I; Singh AK
J Neurosci Res; 2004 May; 76(4):519-27. PubMed ID: 15114624
[TBL] [Abstract][Full Text] [Related]
7. Ethyl pyruvate protects PC12 cells from oxygen-glucose deprivation: A potential role in ischemic cerebrovascular disease.
Li W; Lou J; Wei L; Bai H; Zhang Y; He Y
Biomed Pharmacother; 2017 Aug; 92():168-174. PubMed ID: 28538193
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory and anti-excitoxic effects of diethyl oxopropanamide, an ethyl pyruvate bioisoster, exert robust neuroprotective effects in the postischemic brain.
Lee HK; Kim ID; Kim SW; Lee H; Park JY; Yoon SH; Lee JK
Sci Rep; 2017 Feb; 7():42891. PubMed ID: 28220827
[TBL] [Abstract][Full Text] [Related]
9. Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult.
Piao CS; Kim JB; Han PL; Lee JK
J Neurosci Res; 2003 Aug; 73(4):537-44. PubMed ID: 12898538
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
Dong W; Li N; Gao D; Zhen H; Zhang X; Li F
J Vasc Surg; 2008 Sep; 48(3):709-14. PubMed ID: 18572362
[TBL] [Abstract][Full Text] [Related]
11. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
Shi QJ; Wang H; Liu ZX; Fang SH; Song XM; Lu YB; Zhang WP; Sa XY; Ying HZ; Wei EQ
Neuroscience; 2015 Apr; 291():53-69. PubMed ID: 25681271
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effects of OBA-09, a salicylic acid/pyruvate ester, in the postischemic brain.
Lee HK; Kim SW; Jin Y; Kim ID; Park JY; Yoon SH; Lee JK
Brain Res; 2013 Aug; 1528():68-79. PubMed ID: 23850644
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect.
Lim CM; Kim SW; Park JY; Kim C; Yoon SH; Lee JK
J Neurosci Res; 2009 Mar; 87(4):1037-45. PubMed ID: 18855941
[TBL] [Abstract][Full Text] [Related]
14. Antithrombin gamma attenuates macrophage/microglial activation and brain damage after transient focal cerebral ischemia in mice.
Nakano T; Nakamura Y; Irie K; Okano S; Morimoto M; Yamashita Y; Kozako T; Hayashi T; Honda SI; Matsuo K; Kamimura H; Ishikura H; Egawa T; Mishima K
Life Sci; 2020 Jul; 252():117665. PubMed ID: 32305521
[TBL] [Abstract][Full Text] [Related]
15. Propofol protects against focal cerebral ischemia via inhibition of microglia-mediated proinflammatory cytokines in a rat model of experimental stroke.
Zhou R; Yang Z; Tang X; Tan Y; Wu X; Liu F
PLoS One; 2013; 8(12):e82729. PubMed ID: 24349350
[TBL] [Abstract][Full Text] [Related]
16. Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519.
Williams AJ; Berti R; Dave JR; Elliot PJ; Adams J; Tortella FC
Stroke; 2004 May; 35(5):1186-91. PubMed ID: 15060320
[TBL] [Abstract][Full Text] [Related]
17. Accelerated cerebral ischemic injury by activated macrophages/microglia after lipopolysaccharide microinjection into rat corpus callosum.
Lee JC; Cho GS; Kim HJ; Lim JH; Oh YK; Nam W; Chung JH; Kim WK
Glia; 2005 Apr; 50(2):168-81. PubMed ID: 15702482
[TBL] [Abstract][Full Text] [Related]
18. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat.
Dohare P; Garg P; Jain V; Nath C; Ray M
Behav Brain Res; 2008 Nov; 193(2):289-97. PubMed ID: 18611416
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats.
Chauhan A; Sharma U; Jagannathan NR; Reeta KH; Gupta YK
Behav Brain Res; 2011 Dec; 225(2):603-9. PubMed ID: 21903138
[TBL] [Abstract][Full Text] [Related]
20. Eupatilin exerts neuroprotective effects in mice with transient focal cerebral ischemia by reducing microglial activation.
Sapkota A; Gaire BP; Cho KS; Jeon SJ; Kwon OW; Jang DS; Kim SY; Ryu JH; Choi JW
PLoS One; 2017; 12(2):e0171479. PubMed ID: 28178289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
